Sonoma Pharmaceuticals, Inc.
SNOA· Nasdaq
SNOASonoma Pharmaceuticals, Inc.
Filed Jun 21, 2016 · 10-K · 82 days after period end · 0001019687-16-006749
derived · Computed from the longer spans the company filed.
| Metric | Q4 2016dderived from reported figures | Q4 2015dderived from reported figures | Q4 2014dderived from reported figures | Q4 2010dderived from reported figures |
|---|---|---|---|---|
| Revenue | — | $3.98M | $2.91M | $2.71M |
| Net Income | -$2.91M | -$1.50M | $7.46M | -$1.69M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sonoma Pharmaceuticals, Inc. · CIK 1367083 · Engraved from SEC EDGAR
ended Mar 31, 2016 · filed Jun 21, 2016 · 82 d after period end
